Literature DB >> 17920273

The benefits of using diverse animal models for studying pertussis.

Shokrollah Elahi1, James Holmstrom, Volker Gerdts.   

Abstract

Pertussis, a respiratory disease caused by infection with Bordetella pertussis, represents one of the most devastating diseases in infants and young children worldwide. Significant research efforts over the last five decades have led to the introduction of two types of vaccines, which are now available worldwide and which have significantly reduced the global incidence of pertussis. The use of animal models and, in particular, the mouse model has benefited in the development of these vaccines tremendously. However, open questions regarding the duration of immunity, the type of immune response needed for protection and the role of mucosal and innate immunity in disease protection still remain. Here, we review the various animal models available currently and their benefits for studying this important disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17920273     DOI: 10.1016/j.tim.2007.09.003

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  31 in total

1.  Immunogenic characterization and protective efficacy of recombinant CsgA, major subunit of curli fibers, against Vibrio parahaemolyticus.

Authors:  Sweta Karan; Devapriya Choudhury; Aparna Dixit
Journal:  Appl Microbiol Biotechnol       Date:  2021-01-06       Impact factor: 4.813

2.  Airborne transmission of Bordetella pertussis.

Authors:  Jason M Warfel; Joel Beren; Tod J Merkel
Journal:  J Infect Dis       Date:  2012-07-17       Impact factor: 5.226

Review 3.  Nonhuman primate and human challenge models of pertussis.

Authors:  Tod J Merkel; Scott A Halperin
Journal:  J Infect Dis       Date:  2014-04-01       Impact factor: 5.226

4.  Acellular pertussis vaccination facilitates Bordetella parapertussis infection in a rodent model of bordetellosis.

Authors:  Gráinne H Long; Alexia T Karanikas; Eric T Harvill; Andrew F Read; Peter J Hudson
Journal:  Proc Biol Sci       Date:  2010-03-03       Impact factor: 5.349

Review 5.  The route less taken: pulmonary models of enteric Gram-negative infection.

Authors:  Michael L Fisher; Wei Sun; Roy Curtiss
Journal:  Pathog Dis       Date:  2013-11-21       Impact factor: 3.166

6.  Screening and Genomic Characterization of Filamentous Hemagglutinin-Deficient Bordetella pertussis.

Authors:  Michael R Weigand; Lucia C Pawloski; Yanhui Peng; Hong Ju; Mark Burroughs; Pamela K Cassiday; Jamie K Davis; Marina DuVall; Taccara Johnson; Phalasy Juieng; Kristen Knipe; Vladimir N Loparev; Marsenia H Mathis; Lori A Rowe; Mili Sheth; Margaret M Williams; M Lucia Tondella
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

7.  Protective Role of Passively Transferred Maternal Cytokines against Bordetella pertussis Infection in Newborn Piglets.

Authors:  Shokrollah Elahi; David R Thompson; Jill Van Kessel; Lorne A Babiuk; Volker Gerdts
Journal:  Infect Immun       Date:  2017-03-23       Impact factor: 3.441

8.  Nonhuman primate model of pertussis.

Authors:  Jason M Warfel; Joel Beren; Vanessa K Kelly; Gloria Lee; Tod J Merkel
Journal:  Infect Immun       Date:  2012-01-17       Impact factor: 3.441

9.  Quantification of the adenylate cyclase toxin of Bordetella pertussis in vitro and during respiratory infection.

Authors:  Joshua C Eby; Mary C Gray; Jason M Warfel; Christopher D Paddock; Tara F Jones; Shandra R Day; James Bowden; Melinda D Poulter; Gina M Donato; Tod J Merkel; Erik L Hewlett
Journal:  Infect Immun       Date:  2013-02-19       Impact factor: 3.441

10.  Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model.

Authors:  Jason M Warfel; Lindsey I Zimmerman; Tod J Merkel
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.